A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease

NCT05206084 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
DEVICE: Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System

Sponsor

Biotyx Medical (Shenzhen) Co., Ltd.